益生菌+战略
Search documents
微康益生菌“益生菌+”战略亮相晋江 引领休闲食品健康升级新浪潮
Zhong Guo Shi Pin Wang· 2025-07-22 07:20
Core Insights - The conference highlighted the innovative application of probiotics in the snack food industry, focusing on health and nutrition upgrades through diverse product forms [1][10]. Group 1: Probiotic Innovations - The "Probiotic+" strategy aims to expand application boundaries and integrate health upgrades into snack foods, creating differentiated competitive advantages [2]. - Key probiotic strains showcased include BLa80, LRa05, Akk11, and BC99, each with extensive clinical research backing their health benefits [2][3][7]. - BLa80 is recognized for its clinical studies on infant health and gut regulation, while LRa05 focuses on women's health and allergy improvement [2][7]. Group 2: Clinical Evidence and Research - The company emphasizes the importance of clinical evidence in validating probiotic functions and enhancing health food credibility [5][7]. - A robust clinical research system has been established, covering various demographics and health aspects, including gastrointestinal health and emotional well-being [7]. - The commitment to clinical research is seen as essential for building consumer trust and supporting product efficacy claims [7]. Group 3: Product Development and Consumer Trends - Innovative product forms such as probiotic gummies, mineral water, and chewable tablets cater to consumer demands for convenient and enjoyable health solutions [8]. - The focus on integrating probiotics into everyday consumption aligns with the growing consumer interest in healthy snacks, with 76% of consumers seeking healthier options [2]. Group 4: Industry Vision and Future Directions - The conference underscored the need for the snack food industry to innovate beyond traditional methods, integrating health strategies into product development [10]. - The vision of promoting human health and environmental sustainability through probiotics aligns with industry calls for sustainable development [10].